Wegovy news and trends

J&J’s Medical Device Sales Feel the Side Effects of Weight-Loss Drugs 
Healthcare // October 17, 2023

Riding high, Johnson & Johnson reported pharmaceutical sales worth $13.89 billion on Tuesday (Oct 17), a year-over-year growth exceeding 5%.  The pharmaceuticals driving its growth are Darzalex, a biologic used for multiple myeloma, and Erleada, a prostate cancer treatment, in addition to several other oncology...

Why Walmart Grocery Sales Are at Risk
Retail // October 04, 2023

Walmart has reportedly found that customers who buy appetite-suppressing medications like the diabetes drug Ozempic are buying less food. The retailer is analyzing anonymized data on shopper populations to gain insights into changes in sales patterns among individuals who are taking the drug compared to those...

Rite Aid Rides Ozempic Wave but Fails to Profit  
Retail // June 29, 2023

During its fiscal first quarter, Rite Aid reported a boost in pharmacy sales, attributed to the introduction of a new category of drugs.  Pharmacy sales rose 3.4% year over year, fueled by the demand for Ozempic and other GLP-1 receptor agonists. These medications are prescribed...

Quick Reads
Consumers on Weight Loss Drugs Expected to Spend Double on New Clothes After Losses

December 03, 2023
The rising popularity of certain weight loss drugs might end up helping apparel makers. That’s according to a recent survey by investment banking firm Stifel, the subject of a Saturday (Dec. 2) report from Seeking Alpha.  That survey found that 15% of respondents are on GLP-1 medications such as Mounjaro, Wegovy and Ozempic. Another 21% said they’d […]

Why Walmart Grocery Sales Are at Risk

October 04, 2023
Walmart has reportedly found that customers who buy appetite-suppressing medications like the diabetes drug Ozempic are buying less food. The retailer is analyzing anonymized data on shopper populations to gain insights...